Krempa David sold ETON
May 22, 2026 · Form 4 insider transaction
Krempa David sold 32,963 shares of Eton Pharmaceuticals, Inc. at $33.22 per share, a transaction worth $1.10M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Disposed (sell-side)
Shares
32,963
Price
$33.22
Total value
$1.10M
InsiderKrempa David
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 22, 2026
Filing dateMay 27, 2026
Shares owned after35,083
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.; The shares were sold in multiple trades at prices ranging from $32.67 to $33.65. The price reported above reflects the weighted average sales price.